| Article
I think that buprenorphine actually should be one of the first line opioids. Pharmacologically, it's really a different animal. It's in the same kingdom, but just a different animal. Buprenorphine is available in two products that are specifically FDA approved for pain. Belbuca, which is the buccal...
| Article
Researchers from Ohio State University have completed what they report as the first study of the network structure of an encrypted online drug distribution network, examining patterns of behavior between buyers and sellers of illicit opioids. They report that first-time buyers on the so-called...
| Article
Results from 3 multicenter clinical trials conducted in the Netherlands have returned discouraging news on the effectiveness of radiofrequency denervation for the treatment of chronic low back pain (cLBP). The studies sought to evaluate the effectiveness of radiofrequency denervation, a commonly...
| Article
A recent article appearing in The Washington Post discusses the incidence of complex regional pain syndrome (CRPS) in children, including the reasons why certain populations such as teen girls who are high achievers seem to be at elevated risk for the condition. Also termed amplified musculoskeletal...
| Article
A news release from Hospital for Special Surgery (HSS) offers recommendations for the treatment of carpal tunnel syndrome, particularly with respect to the advantages of early and proactive diagnosis and treatment. Daniel Osei, MD, a hand surgeon at HSS commented, “When you think of carpal tunnel...
| Video
Public policy reaction to the opioid crisis has significant implications for practitioners and their patients with pain. Attorney Michael Barnes looks at the current federal and state-level regulatory picture, and at some benefits, drawbacks, and unintended consequences of regulatory response.
| Article
Buprenorphine was approved for the treatment of opioid use disorder in 2002, with the stipulation that prescribing clinicians obtain a waiver from the Substance Use and Mental Health Services Administration (SAMHSA), and with limitations on how many patients those authorized prescribers may treat in...
| Article
Researchers from the Milken Institute School of Public Health at George Washington University recently completed a comparative analysis of the impact of Medicaid expansions on states’ abilities to respond to the opioid abuse crisis. By contrasting states that have expanded Medicaid coverage with...
| Article
In a recent press release, the marketing research and strategic planning firm Pain Insights, Inc., announced the publication of a new study of patient views on the use of opioids, nonopioid analgesics, and nonpharmacologic therapies for the management of chronic pain. The study was undertaken to...
| Article
I think the essence of how to move forward in treating these comorbid conditions is to become more specific in how we define depression. It’s a word that is general, has a lot of different meanings, and when you think about it from a clinical perspective, there really are many different types of...